Literature DB >> 7473778

Molecular changes of titin in left ventricular dysfunction as a result of chronic hibernation.

J Ausma1, D Fürst, F Thoné, B Shivalkar, W Flameng, K Weber, F Ramaekers, M Borgers.   

Abstract

Cardiomyocytes of chronic hibernating myocardium are affected by partial to complete loss of sarcomeres, accumulation of glycogen, adaptations in size and shape of mitochondria, reorganisation of nuclear chromatin and depletion of sarcoplasmic reticulum. The nature of these changes, which from a purely morphologic viewpoint are akin to dedifferentiation, needed further clarification at the molecular level. For this purpose we have studied the expression and reorganization of titin, one of the earliest markers of cardiomyocytes differentiation. By use of monoclonal antibodies, recognizing different epitopes distributed over the whole length of the titin molecule, we were able to detect changes in its molecular organization as a result of chronic hibernation. The epitopes of the titin molecule attached to the Z-disc and those present close to the M-line remained detectable at all stages of hibernation, while epitopes at the A-I junction and parts of the myosin anchoring region of the molecule became masked or were lost. A fragmented or punctuated appearance of the titin staining pattern with antibodies to A-I junction related epitopes is found in cells which we consider to represent a more advanced stage of dedifferentiation. Changes in the distribution of the titin molecule or its molecular environment in hibernating myocardium resemble at least in part changes occurring during muscle cell differentiation, although in reversed order.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7473778     DOI: 10.1016/0022-2828(95)90056-x

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  12 in total

Review 1.  Hibernating myocardium.

Authors:  R Schulz; G Heusch
Journal:  Heart       Date:  2000-12       Impact factor: 5.994

Review 2.  Hibernating myocardium.

Authors:  John M Canty; James A Fallavollita
Journal:  J Nucl Cardiol       Date:  2005 Jan-Feb       Impact factor: 5.952

Review 3.  Myocardial hibernation and stunning: from physiological principles to clinical practice.

Authors:  S R Redwood; R Ferrari; M S Marber
Journal:  Heart       Date:  1998-09       Impact factor: 5.994

4.  Dedifferentiation of atrial cardiomyocytes as a result of chronic atrial fibrillation.

Authors:  J Ausma; M Wijffels; G van Eys; M Koide; F Ramaekers; M Allessie; M Borgers
Journal:  Am J Pathol       Date:  1997-10       Impact factor: 4.307

Review 5.  Reversible congestive heart failure caused by myocardial hibernation.

Authors:  J M Wilson
Journal:  Tex Heart Inst J       Date:  1999

6.  Titin expression as an early indication of heart and skeletal muscle differentiation in vitro. Developmental re-organisation in relation to cytoskeletal constituents.

Authors:  F T Van der Loop; G J Van Eys; G Schaart; F C Ramaekers
Journal:  J Muscle Res Cell Motil       Date:  1996-02       Impact factor: 2.698

7.  Efficacy of coronary angioplasty for the treatment of hibernating myocardium.

Authors:  F Fath-Ordoubadi; K J Beatt; N Spyrou; P G Camici
Journal:  Heart       Date:  1999-08       Impact factor: 5.994

8.  Dedifferentiated cardiomyocytes from chronic hibernating myocardium are ischemia-tolerant.

Authors:  J Ausma; F Thoné; G D Dispersyn; W Flameng; J L Vanoverschelde; F C Ramaekers; M Borgers
Journal:  Mol Cell Biochem       Date:  1998-09       Impact factor: 3.396

Review 9.  Myocardial stunning and hibernation revisited.

Authors:  Gerd Heusch
Journal:  Nat Rev Cardiol       Date:  2021-02-02       Impact factor: 32.419

10.  Loss of proteostatic control as a substrate for atrial fibrillation: a novel target for upstream therapy by heat shock proteins.

Authors:  Roelien A M Meijering; Deli Zhang; Femke Hoogstra-Berends; Robert H Henning; Bianca J J M Brundel
Journal:  Front Physiol       Date:  2012-02-23       Impact factor: 4.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.